EB Medical Research

What EB Medical Research does

EB Medical Research (legal entity: EB FlevoResearch BV) is an independent Contract Research Organization (CRO) founded in 2001 and headquartered in Almere, Netherlands, with approximately 15 professionals. The firm conducts Phase 2 through Phase 4 clinical drug and nutrition trials on behalf of pharmaceutical companies, hospitals, and research institutions, operating under a professional services revenue model in which sponsors pay for full-service clinical trial execution. Its therapeutic coverage spans cardiovascular, metabolic, respiratory, endocrine, musculoskeletal, psychiatric, and immunological indications, with notable participation in large-scale cardiovascular outcome studies (MARITIME-CV at 7,140 participants, an Lp(a) study at 10,450 participants) and nutrition studies for clients including Danone.

The company's core technology stack consists of ICH-GCP-compliant clinical trial execution with decentralized clinical trial (DCT) capabilities launched in 2022, including remote site initiation, remote monitoring, electronic consent, home visits, and integrations with Microsoft Teams, multiple eCRF platforms, continuous glucose monitoring (CGM), Holter monitoring, and electronic patient diaries. It holds a partner pharmacy relationship enabling investigational product delivery for decentralized settings. All staff are GCP and IATA certified with biennial refresher training, and all protocols receive Medical Ethics Review Committee (METC) approval under Dutch WMO law.

Go-to-market is direct enterprise sales to pharmaceutical sponsors, hospitals, and research institutions, supplemented by referral flow through CRO partnerships (ACRON, Medimere, QPS) and academic alliances (UMC Utrecht, Flevo Ziekenhuis, NIZO). Participant recruitment is conducted in-house via the company website, social media, email newsletter, local signage, and a "Tip a Friend" referral program paying €15-€45 per randomized referral. The firm is founder/management-owned with no disclosed external funding and operates exclusively within the Netherlands.

Name

EB Medical Research

Legal name

EB FlevoResearch BV

Website

https://flevoresearch.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

EB Medical Research is an independent Netherlands-based CRO (EB FlevoResearch BV) founded in 2001 that conducts Phase 2-4 pharmaceutical and nutrition clinical trials, including decentralized and large-scale cardiovascular outcome studies, for pharmaceutical sponsors, hospitals, and research institutions.

Ownership category

akta.pro rank

Product category

Clinical Research Services (Contract Research Organization)

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Clinical trial services
• Contract research organization
• Pharmaceutical clinical research
• Decentralized clinical trials
• Nutrition research studies

Headquarters

HQ city

Almere

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Research Services: EB Medical Research operates as a Contract Research Organization (CRO) providing Phase 2-4 clinical trial services to pharmaceutical companies, hospitals, and research institutions. Revenue is generated through service contracts for executing clinical studies on behalf of sponsors.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

EB Medical Research (EB FlevoResearch BV) is a Netherlands-based contract research organization (CRO) founded in 2001 that conducts Phase 2-4 clinical trials for pharmaceutical companies, hospitals, and research institutions. The company specializes in pharmaceutical and nutrition research, including decentralized clinical trial (DCT) execution, cardiovascular studies, and bioequivalence/bioavailability trials, operating from its clinic in Almere with approximately 15 staff.

Product overview

EB Medical Research (EB FlevoResearch) operates as an independent clinical research center established in 2001, conducting Phase 2-4 pharmaceutical and nutrition research on behalf of pharmaceutical companies, hospitals, and research institutions. The core offering consists of clinical trial services with specialized capabilities in cardiovascular, metabolic, respiratory, and immunological indications. Their portfolio includes traditional site-based trials as well as Decentralized Clinical Trials (DCT) enabling remote participation. The company offers integrated services including patient recruitment databases, professional staffing, and digital data collection through various eCRF systems. Recent innovations include AI-powered infant nutrition research conducted in partnership with Danone, using computer vision algorithms to analyze growth measurements from photos and videos.

Differentiator

Problem solved

Functional benefit

Products and services

• Phase 2-4 Clinical Trial Services

Quantifiable outcome

• High participant retention due to loyal relationships and patient-centered care approach
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability2 records

Feature1 record

Partnerships

Seven partnerships are on record, tiered core and minor.

• ACRONcoreTechnology or IntegrationACRON (A Complete Research Organisation Network) is a CRO partnership network. EB Medical Research collaborates with ACRON for integrated clinical research services.
• MedimerecoreTechnology or IntegrationMedimere is a clinical research organization partner providing additional research capabilities and capacity.
• UMC UtrechtcoreStrategic or Co-development PartnerAcademic medical center collaboration for clinical research and medical expertise.
• Flevo Ziekenhuis (Flevo Hospital)coreStrategic or Co-development PartnerLocal hospital partnership for clinical research collaboration and potential patient referral.
• Precare Trial & RecruitmentminorChannel Partner/ Reseller/ DistributorTrial recruitment partner specializing in patient recruitment for clinical studies.
• Link2TrialsminorChannel Partner/ Reseller/ DistributorOnline patient recruitment platform partner for clinical trial participant acquisition.
• Partner PharmacycoreTechnology or IntegrationPartner pharmacy for IP (Investigational Product) delivery in decentralized trial settings, enabling home visits and remote treatment administration.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Celerion: Clinical CRO specializing in early-phase and bioanalytical services globally; comparable in size and operating model to EB Medical Research's Phase 1 healthy-volunteer and bioanalytical-adjacent work.
• QPS Holdings: Global CRO with early-phase and bioanalytical services; already a named technology/capacity partner of EB Medical Research, making it the closest operational comparable in size, service mix, and therapeutic focus.
• Worldwide Clinical Trials: Mid-sized CRO focused on Phase 2-4 across cardiovascular, metabolic, neuroscience, and rare diseases — directly comparable therapeutic mix and mid-market positioning relative to EB Medical Research.
• Biotrial: European CRO with strong early-phase clinical pharmacology and neuroscience focus plus later-phase services — comparable as a mid-sized, European-rooted clinical research organization.
• Medimere: European clinical research organization partner of EB Medical Research; comparable boutique CRO providing Phase 1-4 services, useful as a like-for-like European peer.
• Ergomed: Mid-sized European-headquartered CRO providing full-service clinical research across oncology, rare disease, and other specialty areas — comparable in scale and full-service Phase 2-4 positioning, with similar boutique-CRO positioning.

Regional players

• NIZO food research: Dutch food and nutrition research organization already partnered with EB Medical Research; directly comparable on the nutrition/functional food research service line from a Dutch base.

Others

• Link2Trials: Online patient recruitment platform partner of EB Medical Research; comparable as a clinical-trial ecosystem enabler and a relevant channel for understanding recruitment-driven CRO value propositions.

Broad incumbents

• SGS Health & Nutrition: Global life sciences services business with clinical research and nutrition/food testing capabilities — comparable on the nutrition/functional food research side that EB Medical Research actively serves.
• Medpace: Mid-to-large global CRO running Phase 1-4 trials across cardiovascular, metabolic, and endocrine indications — directly comparable therapeutic focus but with substantially larger scale and broader geographic reach than EB Medical Research.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/EBMedResearch
• Facebookfacebook.com/FlevoResearch
• LinkedInlinkedin.com/company/ebmedicalresearch

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EB Medical Research